O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+16.19%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.79B
AUM Growth
+$8.79B
(+13%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
37.24%
Holding
144
New
16
Increased
26
Reduced
29
Closed
10
Top Buys
| 1 |
Centene
CNC
|
$118M |
| 2 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$74.8M |
| 3 |
Merck
MRK
|
$69.9M |
| 4 |
AET
Aetna Inc
AET
|
$64.6M |
| 5 |
Viatris
VTRS
|
$50.7M |
Top Sells
| 1 |
Amgen
AMGN
|
$147M |
| 2 |
Neurocrine Biosciences
NBIX
|
$73.1M |
| 3 |
Intuitive Surgical
ISRG
|
$72.9M |
| 4 |
AGN
Allergan plc
AGN
|
$69.8M |
| 5 |
AbbVie
ABBV
|
$55.1M |
Sector Composition
| 1 | Healthcare | 93.33% |
| 2 | Financials | 2.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
BioMarin Pharmaceuticals
BMRN
$11.2B
| $112M | 1.27% | 1,274,100 | – | – |
|
27
Corvus Pharmaceuticals
CRVS
$428M
| $112M | 1.27% | 5,379,349 | – | – |
|
28
Johnson & Johnson
JNJ
$427B
| $110M | 1.25% | 884,600 +26,600 | +3% | +$3.31M |
|
29
Bristol-Myers Squibb
BMY
$96B
| $104M | 1.18% | 1,911,000 +417,500 | +28% | +$22.7M |
|
|
SGYP
30
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $98.6M | 1.12% | 21,153,343 +2,911,945 | +16% | +$13.6M |
|
31
Tenet Healthcare
THC
$16.3B
| $94.8M | 1.07% | 5,352,000 +1,635,300 | +44% | +$29M |
|
32
Glaukos
GKOS
$5.5B
| $89.3M | 1.01% | 1,741,700 -438,300 | -20% | -$22.5M |
|
33
Insmed
INSM
$28.8B
| $84.2M | 0.95% | 4,810,905 -490,900 | -9% | -$8.6M |
|
34
Puma Biotechnology
PBYI
$254M
| $83.5M | 0.95% | 2,245,925 -29,900 | -1% | -$1.11M |
|
35
Thermo Fisher Scientific
TMO
$186B
| $82.1M | 0.93% | 534,200 -265,300 | -33% | -$40.8M |
|
|
BOLD
36
DELISTED
Audentes Therapeutics, Inc
BOLD
| $81.8M | 0.93% | 4,801,638 | – | – |
|
|
VRAY
37
DELISTED
ViewRay, Inc.
VRAY
| $80.5M | 0.91% | 9,458,567 +330,577 | +4% | +$2.81M |
|
38
Ascendis Pharma
ASND
$11.8B
| $76.1M | 0.86% | 2,717,315 | – | – |
|
|
MGLN
39
DELISTED
Magellan Health Services, Inc.
MGLN
| $75.2M | 0.85% | 1,088,727 +287,127 | +36% | +$19.8M |
|
|
AGN.PRA
40
DELISTED
Allergan plc.
AGN.PRA
| $74.8M | 0.85% | +88,200 | New | +$74.8M |
|
|
LOXO
41
DELISTED
Loxo Oncology, Inc
LOXO
| $72.7M | 0.82% | 1,728,000 | – | – |
|
|
AERI
42
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $67.8M | 0.77% | 1,496,000 | – | – |
|
|
MNK
43
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $65.6M | 0.74% | 1,472,700 | – | – |
|
|
INSY
44
DELISTED
Insys Therapeutics, Inc.
INSY
| $63.8M | 0.72% | 6,071,440 | – | – |
|
45
Medtronic
MDT
$119B
| $61.8M | 0.7% | 766,600 | – | – |
|
|
GWPH
46
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $57.6M | 0.65% | 475,900 +79,300 | +20% | +$9.59M |
|
|
EGRX
47
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $55.7M | 0.63% | 671,000 | – | – |
|
|
ACHN
48
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $55.2M | 0.63% | 13,107,200 | – | – |
|
49
Illumina
ILMN
$15.8B
| $54.9M | 0.62% | 321,900 +139,700 | +77% | +$23.8M |
|
50
Gilead Sciences
GILD
$140B
| $54.4M | 0.62% | 800,900 -254,200 | -24% | -$17.3M |
|